Smoking associated with major urologic cancer surgical complications
the ONA take:
According to a study presented at the 2015 annual meeting of the American Urological Association in New Orleans, Louisiana, researchers have found that smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery and that quitting smoking for even just 1 year significantly improves surgical outcomes.
For the study, researchers identified 9,014 patients who underwent surgery for bladder, kidney, or prostate cancer from the American College of Surgeons National Surgical Quality Improvement Program database and identified.
Results showed current smokers had an increased risk for pulmonary and kidney complications and longer duration of hospitalization after prostate cancer surgery. In addition, patients with bladder cancer who currently smoked had an increased risk for requiring further surgery and former smokers had an increased risk for readmission.
Patients with prostate cancer who had not smoked for at least 1 year prior to surgery had a similar risk for surgical complications as non-smokers and had a significantly lower risk than current smokers.
The findings suggest that health care providers should motivate patients to quit smoking prior to undergoing major surgery in order to reduce the risk for complications.
Smokers and previous smokers are more likely to experience complications during and after major urologic cancer surgery.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|